ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Catabasis Pharmaceuticals Inc

Catabasis Pharmaceuticals Inc (CATB)

8,54
0,00
(0,00%)
Geschlossen 28 Dezember 10:00PM
8,54
0,00
( 0,00% )
Vor Marktöffnung: 1:00AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
8,54
Gebot
8,45
Fragen
8,63
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
8,54
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
36.296.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,25
Gewinn pro Aktie (EPS)
-2,01
Erlöse
-
Nettogewinn
-72,89M

Über Catabasis Pharmaceuticals Inc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-

CATB Neueste Nachrichten

Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics, Highlighting New Company Focus

-- Astria Reflects Company’s Patient-Focused Mission -- -- Promising Lead Program STAR-0215 is in Preclinical Development to Prevent Attacks in Hereditary Angioedema -- -- Company to Begin...

Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update. “We are...

Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will be presenting during a fireside chat at the...

Catabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare Conference

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate overview and provide...

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate overview and provide...

 Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides a Corporate Update

 -- QLS-215, a Potential Best-in-Class Monoclonal Antibody Inhibitor of Plasma Kallikrein, Progresses in Preclinical Development for the Treatment of Hereditary Angioedema -- -- Strong Cash...

Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

-- Recently Completed Acquisition of Quellis Biosciences Includes QLS-215, a Potential Best-in-Class Monoclonal Antibody Inhibitor of Plasma Kallikrein in Preclinical Development for the...

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences   

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, plans to present a corporate overview and provide...

Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.

Acquisition Includes QLS-215, a Potential Best-in-Class Monoclonal Antibody Inhibitor of Plasma Kallikrein in Preclinical Development for the Treatment of Hereditary Angioedema Company Plans to...

Catabasis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides a Corporate Update

-- Cash and Cash Equivalents Totaled $52.9 Million as of September 30, 2020 -- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today reported financial results for...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CATB - Frequently Asked Questions (FAQ)

What is the current Catabasis Pharmaceuticals share price?
The current share price of Catabasis Pharmaceuticals is US$ 8,54
How many Catabasis Pharmaceuticals shares are in issue?
Catabasis Pharmaceuticals has 36.296.000 shares in issue
What is the market cap of Catabasis Pharmaceuticals?
The market capitalisation of Catabasis Pharmaceuticals is USD 309,97M
What is the 1 year trading range for Catabasis Pharmaceuticals share price?
Catabasis Pharmaceuticals has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Catabasis Pharmaceuticals?
The price to earnings ratio of Catabasis Pharmaceuticals is -4,25
What is the reporting currency for Catabasis Pharmaceuticals?
Catabasis Pharmaceuticals reports financial results in USD
What is the latest annual profit for Catabasis Pharmaceuticals?
The latest annual profit of Catabasis Pharmaceuticals is USD -72,89M
What is the registered address of Catabasis Pharmaceuticals?
The registered address for Catabasis Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Catabasis Pharmaceuticals website address?
The website address for Catabasis Pharmaceuticals is www.astriatx.com
Which industry sector does Catabasis Pharmaceuticals operate in?
Catabasis Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AALAmerican Airlines Group Inc
US$ 17,34
(0,00%)
271,28k
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69,73
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,21
(0,00%)
3,82k
AACGATA Creativity Global
US$ 0,762551
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 17,34
(0,00%)
271,28k
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69,73
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,21
(0,00%)
3,82k
AACGATA Creativity Global
US$ 0,762551
(0,00%)
0
NXUNXU Inc
US$ 0,2434
(0,00%)
122,23M
WATTEnergous Corporation
US$ 0,4112
(0,00%)
65,17M
VINCVincerx Inc
US$ 0,194
(0,00%)
27,72M
INTZIntrusion Inc
US$ 2,16
(0,00%)
26,19M
SMXSMX Security Matters Public Company
US$ 0,3536
(0,00%)
25,31M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock